| National survey on the effect of oncology drug shortages on cancer care A McBride, LM Holle, C Westendorf, M Sidebottom, N Griffith, RJ Muller, ... American journal of health-system pharmacy 70 (7), 609-617, 2013 | 142 | 2013 |
| Pegaspargase: an alternative? LM Holle Annals of Pharmacotherapy 31 (5), 616-624, 1997 | 104 | 1997 |
| Oncology pharmacists in health care delivery: vital members of the cancer care team LM Holle, L Boehnke Michaud Journal of oncology practice 10 (3), e142-e145, 2014 | 91 | 2014 |
| Pharmacists' roles in oncology pharmacy services: Results of a global survey LM Holle, CS Harris, A Chan, RJ Fahrenbruch, BA Labdi, JE Mohs, ... Journal of Oncology Pharmacy Practice 23 (3), 185-194, 2017 | 68 | 2017 |
| Demonstrating the value of the oncology pharmacist within the healthcare team E M Segal, J Bates, SL Fleszar, LM Holle, J Kennerly-Shah, M Rockey, ... Journal of Oncology Pharmacy Practice 25 (8), 1945-1967, 2019 | 65 | 2019 |
| Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer JM Patel, LM Holle, JM Clement, T Bunz, C Niemann, KW Chamberlin Journal of oncology pharmacy practice 22 (6), 777-783, 2016 | 64 | 2016 |
| Implementation of a virtual dispensing simulator to support US pharmacy education M Ferrone, C Kebodeaux, J Fitzgerald, L Holle Currents in Pharmacy Teaching and Learning 9 (4), 511-520, 2017 | 49 | 2017 |
| The expanding role of the oncology pharmacist LM Holle, EM Segal, KD Jeffers Pharmacy 8 (3), 130, 2020 | 47 | 2020 |
| Physician–pharmacist collaboration for oral chemotherapy monitoring: insights from an academic genitourinary oncology practice LM Holle, S Puri, JM Clement Journal of Oncology Pharmacy Practice 22 (3), 511-516, 2016 | 47 | 2016 |
| Meeting pharmacy educational outcomes through effective use of the virtual simulation MyDispense V Mak, J Fitzgerald, L Holle, SE Vordenberg, C Kebodeaux Currents in Pharmacy Teaching and Learning 13 (7), 739-742, 2021 | 43 | 2021 |
| Discovery, Development, and clinical applications of bortezomib. L Jung, L Holle, WS Dalton Oncology (Williston Park, NY) 18 (14 Suppl 11), 4-13, 2004 | 40 | 2004 |
| Use of cannabis and cannabinoids in patients with cancer L Sawtelle, LM Holle Annals of Pharmacotherapy 55 (7), 870-890, 2021 | 35 | 2021 |
| International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care LM Holle, T Bilse, RM Alabelewe, PE Kintzel, EA Kandemir, CJ Tan, ... Journal of Oncology Pharmacy Practice 27 (4), 785-801, 2021 | 23 | 2021 |
| Integration of a virtual dispensing simulator “MyDispense” in an experiential education program to prepare students for community introductory pharmacy practice experience AE Johnson, J Barrack, JM Fitzgerald, DM Sobieraj, LM Holle Pharmacy 9 (1), 48, 2021 | 22 | 2021 |
| Valproate in status epilepticus LM Holle, BE Gidal, DM Collins Annals of Pharmacotherapy 29 (10), 1042-1044, 1995 | 22 | 1995 |
| Outpatient management of febrile neutropenia associated with cancer chemotherapy: risk stratification and treatment review N Pherwani, JM Ghayad, LM Holle, EL Karpiuk American Journal of Health-System Pharmacy 72 (8), 619-631, 2015 | 20 | 2015 |
| Pharmacist intervention in colorectal cancer screening initiative LM Holle, J Levine, T Buckley, CM White, C White, MJ Hadfield Journal of the American Pharmacists Association 60 (4), e109-e116, 2020 | 19 | 2020 |
| Delayed hypersensitivity reaction related to the use of pegfilgrastim A Dadla, S Tannenbaum, B Yates, L Holle Journal of Oncology Pharmacy Practice 21 (6), 474-477, 2015 | 18 | 2015 |
| Ledipasvir–Sofosbuvir: A Once‐Daily Oral Treatment Option for Chronic Hepatitis C Virus Genotype 1 Infection CM Jensen, LM Holle Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (5 …, 2016 | 17 | 2016 |
| Potential role of rituximab in metastatic castrate-resistant prostate cancer P Bindal, SAA Jalil, LM Holle, JM Clement Journal of Oncology Pharmacy Practice 25 (6), 1509-1511, 2019 | 14 | 2019 |
